Tissue Oximeter Intraoperative Sensor
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 8 of these applications claim priority to application 12/623,945, filed Nov 23, 2009. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,527,022 | Tissue Oximeter Intraoperative Sensor In force · High confidence | ViOptix Inc. | In force | High confidence | ||
| US 9,060,720 | Tissue Oximeter Intraoperative Sensor In force · High confidence | ViOptix Inc. | In force | High confidence | ||
| US 9,351,686 | Tissue Oximeter Intraoperative Sensor In force · High confidence | ViOptix Inc. | In force | High confidence | ||
| US 9,706,954 | Tissue Oximeter Intraoperative Sensor In force · High confidence | ViOptix Inc. | In force | High confidence | ||
| US 10,165,970 | Tissue Oximeter Intraoperative Sensor In force · High confidence | ViOptix, Inc. | In force | High confidence | ||
| US 10,624,565 | Tissue Oximeter Intraoperative System In force · High confidence | ViOptix, Inc. | In force | High confidence | ||
| US 11,284,822 | Tissue Oximeter Intraoperative System In force · High confidence | ViOptix, Inc. | In force | High confidence | ||
| US 8,290,558 | Tissue Oximeter Intraoperative Sensor In force · High confidence | Vioptix Inc. | In force | High confidence | ||
| US 12,478,294 | Tissue Oximeter Intraoperative System In force · Medium confidence | ViOptix, Inc. | In force | Medium confidence |
9 of 9 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.